Alexandra Cameron

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

Alexandra Cameron, Margaret Ewen, Dennis Ross‐Degnan et al. · The Lancet · 2008 · 943 citations

Public Affairs, Economics, Health Policy +16

The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance

Hatim Sati, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2025 · 560 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries

Alexandra Cameron, Ilse Roubos, Margaret Ewen et al. · Bulletin of the World Health Organization · 2011 · 189 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Utilization Review +16

Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data

Maaike S. M. van Mourik, Alexandra Cameron, Marg Ewen et al. · BMC Cardiovascular Disorders · 2010 · 182 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +17

Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?

Alexandra Cameron, Aukje K. Mantel‐Teeuwisse, Hubert G.M. Leufkens et al. · Value in Health · 2012 · 175 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +12